government
Evidence pageAlofisel: EPAR
European Medicines Agency
accessed Sep 18, 2026Updated Sep 19, 2026
Original source
https://www.ema.europa.eu/en/medicines/human/EPAR/alofisel
ema.europa.eu
Verification
| Verification | Not yet verified |
| Evidence level | — |
| Source | government |
| Link status | Reachable at last check |
Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise. Source policy
Cited by (7)
FactAdipose-derived Stem Cell: EU status of darvadstrocel (Alofisel) = Allogeneic adipose-derived product; authorised 2018-03-23 for complex perianal fistulas in Crohn's disease; marketing authorisation withdrawn 2024-12-13 at holder's requestAnswerIs stem cell therapy FDA approved?AnswerWhat conditions can stem cell therapy treat?AnswerWhat are the risks of stem cell therapy?AnswerHow do I know if a stem cell clinic is legitimate?AnswerIs stem cell therapy legal in South Korea?ArticleStem Cell Therapy: Established Uses, Approved Products, Risks and How to Check a Treatment